Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

ClinicalTrials.gov ID: NCT02558439

Public ClinicalTrials.gov record NCT02558439. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging 24-Week Study to Evaluate the Safety and Efficacy of a Single Injection of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety and efficacy of a single injection of CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.

Study identification

NCT ID
NCT02558439
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Centrexion Therapeutics
Industry
Enrollment
175 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
45 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2015
Primary completion
Sep 30, 2016
Completion
Jan 31, 2017
Last update posted
Aug 7, 2017

2015 – 2017

United States locations

U.S. sites
22
U.S. states
9
U.S. cities
21
Facility City State ZIP Site status
Achieve Clinical Research, LLC Birmingham Alabama 35216
Advanced Arizona Clinical Research Tucson Arizona 85704
Dream Team Clinical Research, LLC Anaheim California 92801
Hope Clinical Research, LLC Canoga Park California 91303
TriWest Research Associates El Cajon California 92020
BioSolutions Clinical Research Center La Mesa California 91941
Axis Clinical Trials Los Angeles California 90036
Avail Clinical Research, LLC DeLand Florida 32720
Finlay Research Clinic Hialeah Florida 33012
Eastern Research Hialeah Florida 33013
Sunrise Medical Research Lauderdale Lakes Florida 33319
M&M Medical Center, Inc Miami Florida 85704
Compass Research, LLC Orlando Florida 32806
Compass Research, LLC The Villages Florida 32162
Clinical Research Atlanta Stockbridge Georgia 30281
The Center for Pharmaceutical Research Kansas City Missouri 64114
Drug Trials America Hartsdale New York 10530
Manhattan Medical Research Practice New York New York 10016
Wake Research Associates, LLC Raleigh North Carolina 27612
University Orthopedics Center Altoona Pennsylvania 16602
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
University Orthopedics Center State College Pennsylvania 16801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02558439, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2017 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02558439 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →